1. Home
  2. UTG vs SHC Comparison

UTG vs SHC Comparison

Compare UTG & SHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

UTG

Reaves Utility Income Fund of Beneficial Interest

HOLD

Current Price

$40.83

Market Cap

3.8B

Sector

Finance

ML Signal

HOLD

Logo Sotera Health Company

SHC

Sotera Health Company

HOLD

Current Price

$15.30

Market Cap

4.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UTG
SHC
Founded
N/A
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
4.4B
IPO Year
2003
2020

Fundamental Metrics

Financial Performance
Metric
UTG
SHC
Price
$40.83
$15.30
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$20.33
AVG Volume (30 Days)
197.8K
3.7M
Earning Date
01-01-0001
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
68.75
EPS
N/A
0.09
Revenue
N/A
$1,163,617,000.00
Revenue This Year
N/A
$7.51
Revenue Next Year
N/A
$6.00
P/E Ratio
N/A
$170.39
Revenue Growth
N/A
5.74
52 Week Low
$33.50
$10.80
52 Week High
$43.90
$19.85

Technical Indicators

Market Signals
Indicator
UTG
SHC
Relative Strength Index (RSI) 39.24 48.11
Support Level $38.52 $15.18
Resistance Level $41.89 $16.48
Average True Range (ATR) 0.84 0.45
MACD -0.32 -0.06
Stochastic Oscillator 16.42 57.59

Price Performance

Historical Comparison
UTG
SHC

About UTG Reaves Utility Income Fund of Beneficial Interest

Reaves Utility Income Fund is a closed-end management investment company. The company's investment objective is to provide a high level of after-tax income and total return consisting of tax-advantaged dividend income and capital appreciation. It invests a portion of its total assets in securities of utility companies, which may include companies in the electric, gas, water, telecommunications sectors, as well as other companies engaged in other infrastructure operations.

About SHC Sotera Health Company

Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.

Share on Social Networks: